Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL (original) (raw)

Indonesian Journal of Urology, 2021

Correlation of serum prostate specific antigen levels and bone scintigraphy in carcinoma prostate

The British Journal of Radiology, 1994

Correlation of PSA Level and ISUP Grade Group with Scintigraphic Bone Metastases Detection in 36 Prostate Cancer Patients

Jean SOSSA

Open Journal of Urology, 2022

View PDFchevron_right

Prostate Specific Antigen Versus Combination of Prostate Specific Antigen and Alkaline Phosphatase in Prediction of Prostate Carcinoma Bone Metastases Detected with Bone Scintigraphy

Marina Vlajkovic

Acta Medica Medianae, 2020

View PDFchevron_right

The Utilization of Gleason Grade as the Primary Criterion for Ordering Nuclear Bone Scan in Newly Diagnosed Prostate Cancer Patients

Muta Issa

The Scientific World JOURNAL, 2009

View PDFchevron_right

Prostate cancer in patients from rural and suburban areas - PSA value, Gleason score and presence of metastases in bone scan

Magdalena Kostkiewicz

Annals of agricultural and environmental medicine : AAEM, 2014

View PDFchevron_right

Value of prostate specific antigen in predicting the existence of bone metastasis in scintigraphy

Ernani Luis Rhoden

International Braz J Urol, 2003

View PDFchevron_right

Correlation Between Bone Metastases and PSA Among Prostate Cancer Patients at Kilimanjaro Christian Medical Centre from June 2018 to May 2019

Alfred Mteta

International Journal of Clinical Urology, 2021

View PDFchevron_right

Update the Indicator Role of Serum PSA Level and Gleason Score of the Biopsy for the Presence of Bony Metastases: Bone Scan Findings in a North African Ethnic Group

Mohamed Abbar

Journal of Cancer Science & Therapy, 2011

View PDFchevron_right

Prostate-specific antigen cutoff value for ordering sodium fluoride positron emission tomography/computed tomography bone scan in patients with prostate cancer

Murat Caloglu

World Journal of Nuclear Medicine, 2018

View PDFchevron_right

Limited Role of Radionuclide Bone Scintigraphy in Patients with Prostate Specific Antigen Elevations After Radical Prostatectomy

Mousumi Banerjee

The Journal of Urology, 1998

View PDFchevron_right

Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? A retrospective study

Rami Alazab

International braz j …, 2010

View PDFchevron_right

Correlation between prostate-specific antigen and bone scan findings in patients with prostate cancer at Grey’s Hospital, KwaZulu-Natal: A retrospective chart review

Wilbert Sibanda

South African Journal of Oncology, 2020

View PDFchevron_right

The value of bone scans to predict survival time in patients with diagnosed prostate cancer: single-center retrospective study

Doğangün Yüksel

Journal of Radiology and Oncology

View PDFchevron_right

Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the royal marsden hospital

R. Thurairaja

BJU International, 2004

View PDFchevron_right

Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients

Arun Singh

International Journal of Radiation Oncology Biology Physics, 2000

View PDFchevron_right

When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available Guidelines and Proposal of a Novel Risk Stratification Tool

Maria Picchio

European Urology, 2010

View PDFchevron_right

Comparison of Ga-68 PSMA positron emission tomography/computerized tomography with Tc-99m MDP bone scan in prostate cancer patients

Ekrem Güner

TURKISH JOURNAL OF MEDICAL SCIENCES

View PDFchevron_right

Prostate-specific antigen and risk of bone metastases in west Africans with prostate cancer

george amoah

World Journal of Nuclear Medicine, 2019

View PDFchevron_right

The Clinical Utility of Prostate-Specific Antigen and Bone Scintigraphy in Prostate Cancer Follow-up

João N . S . Freitas

Journal of Nuclear Medicine, 1991

View PDFchevron_right

Tumor Metastasis Dilemma: Bone Scan And Psa Level In Relation To Prostatic Malignancy Among Sudanese

Prof. Dr. Yousif M . Y Abdallah

2017

View PDFchevron_right

Use and Assessment of PSA in Prostate Cancer

Carl Gjertson

Medical Clinics of North America, 2011

View PDFchevron_right

Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL

LUcas Nogueira

BJU International, 2012

View PDFchevron_right

Application of bone scans for prostate cancer staging: Which guideline shows better result?

Ari chong

Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2014

View PDFchevron_right

When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk …

maria picchio

European urology, 2010

View PDFchevron_right

The value of Gleason score and prostate-specific antigen level in predicting the need for a baseline nuclear bone scan in patients with newly diagnosed 84 prostate cancer cases

Hind Chorfi

International Journal of Cancer Therapy and Oncology, 2015

View PDFchevron_right

PSA density and prostate cancer detection

Wachira Kochakarn

Journal of the Medical Association of Thailand Chotmaihet Thangphaet, 2012

View PDFchevron_right

Is Prostate Biopsy Recommended In Men With a PSA Between 2,5 - 4 ng/mL?

hakan türk

Current Therapeutic Research, 2017

View PDFchevron_right

Usefulness of Total PSA Value in Prostate Diseases Diagnosis

Alden Prcic

Acta Informatica Medica, 2016

View PDFchevron_right

Examining the value PSA=10ng/ml as a cutoff for predicting metastatic bone disease in NaF18 PET/CT bone scans: a pilot study

Aung Myo Win

Journal of Biomedical Graphics and Computing, 2012

View PDFchevron_right

The predictive value of PSA in diagnosis of prostate cancer in non screened population

Snezana Cerovic

Acta chirurgica iugoslavica, 2005

View PDFchevron_right

Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and 10 ng/ml

Silvio henrique maia de almeida

International Braz J Urol, 2007

View PDFchevron_right

Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL (original) (raw)

Related papers